References
- Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. Am Pharm Rev. 2002;5:82–85.
- Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420.
- Vogt M, Kunath K, Dressman JB. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm. 2008;68:283–288.
- Park JH, Choi HK. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Arch Pharm Res. 2015;38:1336–1344.
- Yang Y, Gao J, Ma X, et al. Inclusion complex of tamibarotene with hydroxypropyl-β-cyclodextrin: preparation, characterization, in-vitro and in-vivo evaluation. Asian J Pharm Sci. 2017;12:187–192.
- Hecq J, Deleers M, Fanara D, et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299:167–177.
- Patel DS, Pipaliya RM, Surti N. Liquisolid tablets for dissolution enhancement of a hypolipidemic drug. Indian J Pharm Sci. 2015;77:290–298.
- Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for Embelin: design, characterization and in-vitro studies. Asian J. Pharm Sci. 2015;10:396–404.
- Muley S, Nandgude T, Poddar S. Extrusion–spheronization a promising pelletization technique: In-depth review. Asian J Pharm Sci. 2016;11:684–699.
- Paradkar AR, Maheshwari M, Ketkar AR, et al. Preparation and evaluation of ibuprofen beads by melt solidification technique. Int J Pharm. 2003;255:33–42.
- Jacob S, Shirwaikar A. Preparation and evaluation of microencapsulated fast melt tablets of ambroxol hydrochloride. Indian J Pharm Sci. 2009;71:276–284.
- Young CR, Crowley M, Dietzsch C, et al. Physicochemical properties of film-coated melt-extruded pellets. J Microencapsul. 2007;24:57–71.
- Fadke J, Desai J, Thakkar H. Formulation development of spherical crystal agglomerates of itraconazole for preparation of directly compressible tablets with enhanced bioavailability. AAPS PharmSciTech. 2015;16:1434–1444.
- Saritha D, Bose PSC, Reddy PS, et al. Improved dissolution and micromeritic properties of naproxen from spherical agglomerates: preparation, in vitro and in vivo characterization. Brazilian J Pharm Sci. 2012;48:683–690.
- Tapas AR, Kawtikwar PS, Sakarkar DM. Enhanced dissolution rate of felodipine using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion method. Res Pharm Sci. 2009;4:77–84.
- Ren F, Jing Q, Tang Y, et al. Characteristics of bicalutamide solid dispersions and improvement of the dissolution. Drug Develop Ind Pharm. 2006;32:967–972.
- Meer T, Fule R, Khanna D, et al. Solubility modulation of bicalutamide using porous silica. J Pharm Invest. 2013;43:279–285.
- Li C, Li C, Le Y, et al. Formation of bicalutamide nanodispersion for dissolution rate enhancement. Int J Pharm. 2011;404:257–263.
- Raval MK, Sorathiya KR, Chauhan NP, et al. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability. Drug Develop Ind Pharm. 2013;39:437–446.
- Esbensen KH, Guyot D, Westad F, et al. Multivariate data analysis: in practice: an introduction to multivariate data analysis and experimental design. Oslo: CAMO; 2002. p. 19–97.
- Pilpel N. The flow properties of magnesia. J Pharm Pharmacol. 1964;16:705.
- Carr RL. Evaluating flow properties of solids. Chem Engineer. 1965;72:163–168.
- Hausner H, editor. Friction as a characteristic of metal powders. Stuttgart: Europaeisches Symposium Ueber Pulvermetallurgie; 1969.
- Kawakita K, Tsutsumi Y. A comparison of equations for powder compression. Bcsj. 1966;39:1364–1368.
- Kuno H. In, Kubo T, Jimbo G, Saito E, Takahashi H, Hayakawa S, editors. Powder (Theory and Application). Tokyo: Maruzen; 1979. p. 341–346.
- Mallick S, Pradhan SK, Chandran M, et al. Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil. Result Pharma Sci. 2011;1:1–10.
- Chow AH, Leung MW. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders. Drug Develop Ind Pharm. 1996;22:357–371.
- Teychené S, Sicre N, Biscans B. Is spherical crystallization without additives possible? Chem Engineer Res Design. 2010;88:1631–1638.
- Kumar S, Chawla G, Bansal AK. Spherical crystallization of mebendazole to improve processability. Pharm Develop Technol. 2008;13:559–568.
- Thati J, Rasmuson ÅC. On the mechanisms of formation of spherical agglomerates. Eur J Pharm Sci. 2011;42:365–379.
- Garala KC, Patel JM, Dhingani AP, et al. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box–Behnken experimental design. Int J Pharm. 2013;452:135–156.
- Pingali KC, Saranteas K, Foroughi R, et al. Practical methods for improving flow properties of active pharmaceutical ingredients. Drug Develop Ind Pharm. 2009;35:1460–1469.
- Chen W, Malghan S. Investigation of compaction equations for powders. Powder Technol. 1994;81:75–81.
- Nokhodchi A, Maghsoodi M, Hassan-Zadeh D, et al. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients. Powder Technol. 2007;175:73–81.
- Busignies V, Mazel V, Diarra H, et al. Prediction of the compressibility of complex mixtures of pharmaceutical powders. Int J Pharm. 2012;436:862–868.
- Ringnér M. What is principal component analysis? Nat Biotechnol. 2008;26:303.
- Kubista M, Sjögreen B, Forootan A, et al. Real-time PCR gene expression profiling. Eur Pharm Rev. 2007;12:56.
- Leonard ST, Droege M. The uses and benefits of cluster analysis in pharmacy research. Res Soc Administr Pharm. 2008;4:1–11.
- Zhu M, Ghodsi A. Automatic dimensionality selection from the scree plot via the use of profile likelihood. Comput Statistics Data Anal. 2006;51:918–930.
- Zhang J, Wu C-Y, Pan X, et al. On identification of critical material attributes for compression behaviour of pharmaceutical diluent powders. Materials. 2017;10:845.
- Pattnaik S, Swain K, Bindhani A, et al. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling. Drug Dev Ind Pharm. 2011;37:465–474.
- Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS Pharmscitech. 2006;7:E87.
- Commission EP, Medicines EDftQo, Healthcare. European pharmacopoeia. Vol. 1. France: Council of Europe; 2010. p. 1845.